NCT02396277

Brief Summary

Immobilization after radius fracture seems to increase the risk of developing a Complex regional pain syndrome (CRPS), a condition associated with pain, increased skin sensitivity and reduced epidermal nerve density. The purpose of the study is to determine whether 5-week immobilisation leads to functional and structural sensory changes, and whether the changes are associated with persistent pain. The investigators plan an explorative, pilot study on six consenting patients immobilised after a distal radius fracture. The baseline measurements will be recorded at the day of or the day after trauma: Demographics, psychological and physical comorbidity, pain characteristics and intensity, hand function, health related quality of life (HRQOL), quantitative sensory testing will be recorded while skin biopsies are analyzed for epidermal nerve fiber density. Following variables such as pain characteristics and intensity, hand function, health related quality of life, quantitative sensory testing and skin biopsies will be reassessed when the cast is removed and two months later.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
32mo left

Started May 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
May 2025Dec 2028

First Submitted

Initial submission to the registry

March 17, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 24, 2015

Completed
10.1 years until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

1.6 years

First QC Date

March 17, 2015

Last Update Submit

May 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Changes from baseline in nerve fiber density at five weeks

    ANOVA repeated measurements based on repeated skin biopsies

    From baseline to five weeks after injury

  • Changes from baseline in sensitivity to thermal and tactile stimuli at five weeks

    ANOVA repeated measurements based on repeated sensory quantitative testing

    From baseline to five weeks after injury

Secondary Outcomes (6)

  • Changes from five weeks in nerve fiber density at 13 weeks

    From five weeks to 13 weeks after injury

  • Changes from five weeks in sensitivity to thermal and tactile stimuli at 13 weeks

    From five to 13 weeks after injury

  • Correlation between changes in pain intensity and changes in nerve fiber density

    From baseline to 13 weeks

  • Correlation between changes in pain intensity and changes in sensitivity to thermal and tactile stimuli

    From baseline to 13 weeks

  • Changes from baseline (preinjury) in disability of arm, shoulder and hand are correlated with changes in pain intensity at five and 13 weeks

    From baseline to 13 weeks

  • +1 more secondary outcomes

Interventions

This is not an intervention study; but the patients are subjected to immobilization with a cast as part of a regular clinical treatment for distal radius fracture.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred to the Emergency Clinic at The University Hospital in North Norway Tromso day time

You may qualify if:

  • Consent competence
  • Acute stable distal radius fracture (less than 48 hours)
  • Allocated to conservative treatment with 5-week immobilization

You may not qualify if:

  • Comorbidity which may prevent completion of the study
  • Serious and progressive disease
  • Chronic shoulder disease with limited ROM and function.
  • Sign peripheral nerve injury in the upper extremities
  • Polyneuropathy
  • Demyelination disease
  • Diabetes mellitus
  • Anticoagulants including acetyl salicylic acid (ASA)
  • Allergy to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of North Norway

Tromsø, 9019, Norway

Location

MeSH Terms

Conditions

Colles' FractureWrist Fractures

Interventions

Immobilization

Condition Hierarchy (Ancestors)

Fracture DislocationJoint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesRadius FracturesFractures, BoneWrist InjuriesArm Injuries

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Gunnvald Kvarstein, PhD

    University of Tromso

    STUDY CHAIR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2015

First Posted

March 24, 2015

Study Start

May 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2028

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations